Back to Browse Journals » Integrated Blood Pressure Control » Volume 4

A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals

Authors Cheryl L Laffer, Fernando Elijovich

Published Date January 2011 Volume 2011:4 Pages 1—5

DOI http://dx.doi.org/10.2147/IBPC.S6562

Published 19 January 2011

Cheryl L Laffer1, Fernando Elijovich2
1Section of Hypertension and Vascular Medicine, 2Division of General Internal Medicine, Department of Medicine, Texas A&M Health Sciences Center College of Medicine, Temple, TX USA

Abstract: Recent guidelines for the treatment of hypertension have focused on the need for multiple medications to get most patients to goal blood pressure (BP). Two to three different classes of antihypertensive agents are frequently required, increasing the risk of poor compliance with therapy. Hence, the guidelines have recommended starting with combination therapy in patients with BP that is over 20 mm Hg systolic or 10 mm Hg diastolic above goal. The latest advance in treatment regimen has been the development of triple-therapy combinations of an angiotensin receptor blocker, amlodipine, and hydrochlorothiazide. We review the pathophysiologic rationale for such a combination and the efficacy, safety, and tolerability of the first triple therapy that has become available: valsartan + amlodipine + hydrochlorothiazide. Finally, we suggest that use of triple therapy could improve the accuracy of diagnosing resistant hypertension, an increasingly prevalent and severe condition, by enhancing adherence to treatment and weeding out patients with pseudoresistance. This would allow for implementation of expensive and invasive workup only in those truly resistant patients in whom it is justified.

Keywords: combination therapy, compliance, hypertension control rates, resistant hypertension

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Current perspectives on combination therapy in the management of hypertension

Mallat SG, Itani HS, Tanios BY

Integrated Blood Pressure Control 2013, 6:69-78

Published Date: 17 June 2013

Alternative ultraviolet A lamp for corneal collagen crosslinking

Diaz-Llopis M, Salom D, Garcia-Delpech S, Udaondo P, Garcia-Pous M

Clinical Ophthalmology 2013, 7:557-559

Published Date: 16 March 2013

A physical model for the size-dependent cellular uptake of nanoparticles modified with cationic surfactants

Xu A, Yao M, Xu G, Ying J, Ma W, Li B, Jin Y

International Journal of Nanomedicine 2012, 7:3547-3554

Published Date: 10 July 2012

Advances in dental veneers: materials, applications, and techniques

Pini NP, Aguiar FHB, Lima DAN, Lovadino JR, Terada RS, Pascotto RC

Clinical, Cosmetic and Investigational Dentistry 2012, 4:9-16

Published Date: 10 February 2012

Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy

Gold M, Lorenzl S, Stewart AJ, Morimoto BH, Williams DR, Gozes I

Neuropsychiatric Disease and Treatment 2012, 8:85-93

Published Date: 9 February 2012

A novel educational tool for teaching ocular ultrasound

Mustafa MS, Montgomery J, Atta HR

Clinical Ophthalmology 2011, 5:857-860

Published Date: 23 June 2011

Adult nontwin sib concordance rates for type 2 diabetes, hypertension and metabolic syndrome among Asian Indians: The Indian Atherosclerosis Research Study

Jayashree Shanker, Saikat Kanjilal, Veena S Rao, Ganapathy Perumal, Natesha B Khadrinarasimhiah, et al

Vascular Health and Risk Management 2007, 3:1063-1068

Published Date: 15 January 2007